Clinical Trial

Janus II Feasibility

Recruiting
View on ClinicalTrials.gov →
Summary
The objectives of this study are to evaluate the feasibility of the remedē® Dual Channel System at implant and overnight sleep studies and to assess chronic safety.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-13.
Status change: Not Yet Recruiting → Recruiting 2025-10-28
Trial Details
NCT Number NCT06556693
Lead Sponsor Zoll Medical Corporation
Conditions Sleep Apnea
Enrollment 40 participants
Start Date 2025-08-12
Primary Completion 2028-04 (estimated)
Study Completion 2034-12 (estimated)
Updated on ClinicalTrials.gov 2025-10-29